The clinical decision support systems market is expected to reach USD 1,752.0 million by 2023 from USD 1,001.9 million in 2018, at a CAGR of 11.8%. Growth in the market is primarily driven by the government support and initiatives to drive adoption of HCIT solutions in healthcare, rising incidence of medication errors, rising prominence and usage of big data and mhealth tools, growing adoption of cloud computing in healthcare and partnerships between medical research groups & clinical decision support companies. However, reluctance to adopt mobile CDSS, high investments for IT infrastructure, data security concerns related to cloud-based CDSS, and lack of interoperability is likely to restrain the market to certain extent.
Request a Free Sample copy of This Premium Research Report: https://watchersofmarkets.com/collections/marketsandmarkets/products/clinical-decision-support-systems-market-by-component-services-software-delivery-mode-product-application-model-knowledge-based-type-therapeutic-diagnostic-interactivity-active-passive-patient-care-setting-global-forecasts-to-2023#tab-questions
“Conventional CDSS to dominate the market, by application in 2017”
On the basis of application, the market has been segmented into conventional and advanced CDSS. In 2017, the conventional CDSS segment commanded the largest share of the global CDSS market. However, the advanced CDSS segment is estimated to grow at the highest rate in the forecast period. This is owing to these systems performing additional functions such as population health management, financial decision support, assisting clinicians in real-time evidence-based decision making, treatment planning, and protocol validation.
“Integrated CDSS segment is projected to grow at the highest CAGR during the forecast period.”
Based on product, the clinical decision support systems (CDSS) market is segmented into integrated CDSS and standalone CDSS. Of these, the integrated CDSS segment accounted for the largest market share in 2017. The large share of this segment is majorly attributed to the growing deployments of integrated CDSS. Integrated CDSS are widely used by healthcare providers as they improve the quality of care and health outcomes and reduce medication errors. While using integrated solutions, users can easily switch from one type of application to another without exiting the program.
“Asia Pacific to witness the highest growth during the forecast period.”
Geographically, North America is expected to account for the largest share of the global clinical decision support systems market in 2017, followed by Europe, Asia Pacific, and the Rest of the World (RoW). However, Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2018–2023. Factors such as the presence of a large patient population demanding better healthcare at lower costs, economic growth, implementation of favorable government policies, increasing spending on IT infrastructure by healthcare providers, and growing focus of various market players on emerging Asian countries are driving the growth of the market in this region.
Read more on this report: https://watchersofmarkets.com/collections/marketsandmarkets/products/clinical-decision-support-systems-market-by-component-services-software-delivery-mode-product-application-model-knowledge-based-type-therapeutic-diagnostic-interactivity-active-passive-patient-care-setting-global-forecasts-to-2023
Break of primary participants was as mentioned below:
By Company Type: Tier 1: 50%, Tier 2: 42%, Tier 3: 8%
By Designation: Director Level: 39%, C-Level: 29%, Others: 32%
By Region: North America: 32%, Europe: 24%, APAC: 26%, RoW: 18%
The report includes the study of key players offering clinical decision support systems such as Cerner Corporation (US), McKesson Corporation (US), Epic Systems Corporation Inc. (US), Medical Information Technology, Inc. (US), Philips Healthcare (Netherlands), Allscripts Healthcare Solutions, Inc. (US), Wolters Kluwer Health (US), Hearst Health (US), Elsevier B.V. (Netherlands), and International Business Machines (IBM) Corporation (US).
Research Coverage:
The report segments the global clinical decision support systems market on the basis of component, delivery mode, product, type, model, level of interactivity, application, settings, and region, with analysis and forecasts to 2023. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the solutions offered by top players in the clinical decision support systems market. The report analyzes the clinical decision support systems market, by component, delivery mode, product, type, model, user interactivity, settings, and application
• Product Development/Innovation: Detailed insights on research and development activities and product launches in the clinical decision support systems market
• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the clinical decision support systems market across regions
• Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the clinical decision support systems market
• Competitive Assessment: In-depth assessment of strategies, products, and distribution networks of the leading players in the clinical decision support systems market
Related report:
Clinical Laboratory Services Market by Specialty (Biochemistry Endocrinology Microbiology Hematology Cytology Histopathology Genetic Testing) Providers (Independent Laboratory Reference Laboratory Hospital Laboratory) - Global Forecasts to 2022
The clinical laboratory services market is projected to reach USD 146.14 billion by 2022 from USD 113.44 billion in 2017, at a CAGR of 5.2%. The increasing global burden of target diseases, advancements in clinical diagnostic techniques, and rising government initiatives to improve the quality and affordability of clinical diagnostic testing procedures are the major factors driving the demand for clinical laboratory services market. Factors such as the pricing pressure faced by healthcare payers and providers and the procedural shift from lab-based diagnosis to home-based/point-of-care testing procedures are limiting the growth of the market to a certain extent.
About Us:
We are one of the world's largest market research store bridging you with market research insights, analysis and data from many market research publishers around the globe.
Our experienced market research consultants, from our headquarters (Den Haag, Netherlands) understand client’s research requirements in precise manner and get many proposals on the table suiting your budget and mapping your research goals. Our only motives is to provide clients with precise insights into their respective niche markets; offering them the most comprehensive portfolio of business information products.
Contact:
Watchers of Markets
Henriëtte van der Meydreef 144,2492 JG, Den Haag, Netherlands.
Website:- https://watchersofmarkets.com/
Phone number: +31- 85 888 111 6
Email Id :- sales@watchersofmarkets.com